they received as first treatment one of the following regimens : melphalan ( l-pam ) ( 41 patients ) , cyclophosphamide plus methotrexate plus 5-fluorouracil ( cmf ) ( 16 patients ) , cyclophosphamide plus doxorubicin plus 5-fluorouracil ( caf ) ( 17 patients ) , cyclophosphamide plus doxorubicin plus hexamethylmelamine plus cisplatin ( chad ) ( 13 patients , thiotepa plus methotrexate ( tm ) with fixed rotation with caf ( tm/caf ) ( 17 patients ) , and 6 patients received other chemotherapy as first treatment .
C1327769
thiotepa
C0039871
tm